Hsbc Holdings PLC Boosts Stock Holdings in Concentrix Corporation $CNXC

Hsbc Holdings PLC raised its position in shares of Concentrix Corporation (NASDAQ:CNXC) by 60.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 59,134 shares of the company’s stock after purchasing an additional 22,187 shares during the period. Hsbc Holdings PLC’s holdings in Concentrix were worth $2,459,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of CNXC. Royal Bank of Canada raised its stake in shares of Concentrix by 9.5% in the first quarter. Royal Bank of Canada now owns 47,501 shares of the company’s stock valued at $2,643,000 after buying an additional 4,133 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Concentrix by 75.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock valued at $23,552,000 after buying an additional 181,546 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Concentrix by 17.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company’s stock worth $8,152,000 after acquiring an additional 21,746 shares during the period. Focus Partners Wealth bought a new position in shares of Concentrix during the 1st quarter worth $781,000. Finally, Geneos Wealth Management Inc. increased its holdings in Concentrix by 532.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after acquiring an additional 522 shares during the last quarter. 90.34% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages recently issued reports on CNXC. Canaccord Genuity Group lowered their price objective on Concentrix from $80.00 to $55.00 and set a “buy” rating on the stock in a research note on Wednesday, March 25th. Wall Street Zen lowered shares of Concentrix from a “buy” rating to a “hold” rating in a research report on Saturday, March 28th. Robert W. Baird reduced their target price on shares of Concentrix from $52.00 to $40.00 and set an “outperform” rating for the company in a research note on Wednesday, March 25th. Barrington Research reissued an “outperform” rating and issued a $38.00 price target on shares of Concentrix in a research report on Monday, June 22nd. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Concentrix in a research note on Monday, April 27th. Three research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Concentrix currently has an average rating of “Moderate Buy” and an average price target of $44.33.

Insider Buying and Selling

In other news, CFO Andre S. Valentine bought 2,500 shares of the stock in a transaction on Thursday, April 9th. The shares were acquired at an average cost of $27.95 per share, for a total transaction of $69,875.00. Following the purchase, the chief financial officer directly owned 89,066 shares of the company’s stock, valued at $2,489,394.70. This trade represents a 2.89% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the firm’s stock in a transaction on Wednesday, April 29th. The shares were sold at an average price of $22.25, for a total transaction of $133,500,000.00. Following the completion of the transaction, the insider directly owned 2,773,667 shares of the company’s stock, valued at approximately $61,714,090.75. The trade was a 68.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.90% of the company’s stock.

Key Concentrix News

Here are the key news stories impacting Concentrix this week:

• Negative Sentiment: Concentrix lowered its FY2026 and Q3 2026 guidance below Wall Street expectations, signaling slower demand as clients trim spending. The company now expects FY2026 EPS of $10.83-$11.18 versus consensus near $11.45, and revenue of $9.9 billion-$10.0 billion versus about $10.1 billion. Article: Reuters – Concentrix cuts annual forecast as clients trim spend; shares fall
• Negative Sentiment: Q2 earnings and revenue came in just below estimates, with EPS of $2.63 versus $2.64 expected and revenue of $2.46 billion versus $2.47 billion expected. That small miss adds to investor concern that growth is slowing. Article: Zacks – Concentrix Corporation (CNXC) Misses Q2 Earnings and Revenue Estimates
• Neutral Sentiment: Management highlighted better cash generation and iX Suite momentum, including record quarterly cash from operations of $258 million, adjusted free cash flow of $242 million, and strong growth in iX Suite deals. The company also targeted $630 million-$650 million in FY2026 adjusted free cash flow and more than $120 million in iX Suite ARR, which could help support the stock over time. Article: MSN – Concentrix posts Q2 CY2026 sales in line with estimates but stock drops 24%

Concentrix Stock Up 0.9%

CNXC stock opened at $25.23 on Tuesday. The stock has a 50-day simple moving average of $25.84 and a two-hundred day simple moving average of $32.08. Concentrix Corporation has a twelve month low of $22.05 and a twelve month high of $62.14. The firm has a market capitalization of $1.54 billion, a PE ratio of -1.17, a PEG ratio of 0.31 and a beta of 0.43. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.43.

Concentrix (NASDAQ:CNXC) last announced its quarterly earnings results on Monday, June 29th. The company reported $2.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01). Concentrix had a positive return on equity of 17.80% and a negative net margin of 13.35%.The firm had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.47 billion. During the same period in the previous year, the company posted $2.70 earnings per share. The company’s quarterly revenue was up 1.9% compared to the same quarter last year. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. On average, equities analysts predict that Concentrix Corporation will post 10.42 EPS for the current fiscal year.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.